Pharmacoepidemiological Study of the Use of Antibacterial Agents in the Multi-Speciality Hospitals of St. Petersburg
Abstract
At the initiative of the St. Petersburg's Territorial Fund for Mandatory Medical Insurance a retrospective cross-sectional observational study of the structure and adequacy of antibiotic use was initiated in four multi-specialty hospitals in the city (with a total bed capacity of more than 4 thousand) in 2014. In total, 18,250 medical records of the inpatients were analyzed, of which 2008 cards of the patients receiving antibiotics were selected, the CRFs were filled in according to the selected cards. Subsequently, 1978 of the 2008 CRFs were included in the detailed analysis after the final verification of the electronic database. Of the 1978 antibiotic prescriptions, a microbiological study was assigned in 585 (28%). Each patient received an average of 1.9 courses of antibiotics. In general, the therapy duration was up to two weeks. Short courses (from 1 to 5 days) were prescribed in 51% of cases, in 40% of cases the duration of therapy ranged from 6 to 14 days. Only 9% had to take antibiotics for more than 2 weeks. A total of 60 different antibiotics were used. Ceftriaxone, metronidazole, ciprofloxacin, cefazolin, and cefotaxime accounted for 78% of prescriptions. The most commonly prescribed combination therapy used 2 antibacterial drugs. Perioperative prophylaxis in surgery accounted for 22% of prescriptions, antibiotics were prescribed for the purpose of empirical therapy in 67% of cases. Targeted therapy accounted for only 7% of the total number of medical prescriptions. The duration of primary antibiotic prophylaxis in surgery was up to 24 hours only in 14% of the cases. Adequate antibiotic therapy was prescribed in 26% of the cases of acute pyelonephritis and in 31% of the cases of community-acquired pneumonia. Antibiotics were prescribed in the absence of the signs of bacterial infection documented in the medical history in 35% of the cases. There is an obvious need to take urgent measures to optimize the practice of antibiotic therapy in hospitals of St. Petersburg.
About the Authors
S. V. Sidorenko
Research Institute of Children's Infections; North-West State Medical University named after I.I. Mechnikov
Russian Federation
Russian Federation
A. S. Kolbin
Pavlov First Saint Petersburg State Medical University; Saint Petersburg University
Russian Federation
Russian Federation
S. A. Shlyapnikov
North-West State Medical University named after I.I. Mechnikov; St. Petersburg I.I. Dzhanelidze Research Institute of Emergency Medicine
Russian Federation
Russian Federation
A. M. Kuzhel
Territorial fund of compulsory medical insurance of St. Petersburg
Russian Federation
Russian Federation
A. V. Repina
Territorial fund of compulsory medical insurance of St. Petersburg
Russian Federation
Russian Federation
Yu. V. Lobzin
Research Institute of Children's Infections; North-West State Medical University named after I.I. Mechnikov
Russian Federation
Russian Federation
N. N. Klimko
North-West State Medical University named after I.I. Mechnikov
Russian Federation
Russian Federation
P. K. Yablonsky
Saint Petersburg University
Russian Federation
Russian Federation
V. A. Mazurov
North-West State Medical University named after I.I. Mechnikov
Russian Federation
Russian Federation
A. V. Shchegolev
S.M. Kirov Military Medical Academy
Russian Federation
Russian Federation
A. V. Rudakova
Research Institute of Children's Infections
Russian Federation
Russian Federation
A. R. Danilchenko
Territorial fund of compulsory medical insurance of St. Petersburg
Russian Federation
Russian Federation
N. V. Mukhina
Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
A. Ya. Malikov
Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
Yu. E. Balykina
Saint Petersburg University
Russian Federation
Russian Federation
A. A. Mosikyan
Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
References
1. Spellberg B., Guidos R., Gilbert D. et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46 (2): 155-164.
2. Macgowan A.P.; BSAC Working Parties on Resistance Surveillance. Clinical implications of antimicrobial resistance for therapy. J AntimicrobChemother 2008; 62: Suppl 2: ii105-114.
3. Schwaber M.J., Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60 (5): 913-920.
4. Whitby M., McLaws M.L., Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust.9 2001; 175 (5): 264-267.
5. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. WHО/CDS/CSR/DRS/20012 2001.
6. www.zdrav.ru
7. Приложение 1 к распоряжению Комитета по здравоохранению от 15.06.2012 № 274-р. Правительство Санкт-Петербурга Комитет по здравоохранению. Стандарт административно-территориальный. Протокол ведения больных. Периоперационная антимикробная профилактика инфекций в области хирургического вмешательства
8. Стратегия и тактика применения антимикробных средств в лечебных учреждениях России. Российские национальные рекомендации. Под ред. В.С. Савельева, Б.Р. Гельфанда, С.В. Яковлева. М.: 2012
9. Guidelines of European Association of Urology 2015 http://www.uroweb.org/ professional-resources/guidelines
10. Рекомендации по ведению больных с инфекциями почек, мочевых путей и мужских половых органов - EAU. Европейской урологическая ассоциация EAU. 2007
11. Чучалин А.Г., Синопальников А.И., Козлов P.C., Тюрин И.Е., Рачина С.А. Внебольничная пневмония у взрослых. Практические рекомендации по диагностике, лечению и профилактике. М.: 2010; 106
12. Partina I., Kalinogorskaya O., Kojima S., Gostev V., Volkova M., Ageevets V., Lobzin Y., Sidorenko S. Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia. Jpn J Antibiot 2016; 69 (1): 41-51
Review
For citations:
Sidorenko S.V., Kolbin A.S., Shlyapnikov S.A., Kuzhel A.M., Repina A.V., Lobzin Yu.V., Klimko N.N., Yablonsky P.K., Mazurov V.A., Shchegolev A.V., Rudakova A.V., Danilchenko A.R., Mukhina N.V., Malikov A.Ya., Balykina Yu.E., Mosikyan A.A. Pharmacoepidemiological Study of the Use of Antibacterial Agents in the Multi-Speciality Hospitals of St. Petersburg. Antibiot Khimioter = Antibiotics and Chemotherapy. 2017;62(7-8):17-23. (In Russ.)
Views:
337
Email this article 